Consolidated revenue from operations for the quarter ended December 31, 2025 at ₹ 3,550 Cr and EBITDA at ₹ 345 Cr



2nd February 2026: Tata Chemicals Limited today declared its financial results for the quarter and nine months ended December 31, 2025.

 

Commenting on the results, R. Mukundan, Managing Director & CEO, Tata Chemicals Limited, said, “Soda ash markets continue to remain oversupplied, with high inventory levels across most regions. Prices softened further during Q3FY26, reflecting adverse demand - supply dynamics. As a result, the near-term outlook for the soda ash market remains subdued and uncertain, with limited visibility on any immediate improvement.

 

Despite these headwinds, the Company’s standalone performance has been supported by higher volumes and disciplined cost management, resulting in a resilient operating performance. The reconfiguration of the UK operations has been completed, with a strategic shift toward value-added, non-cyclical products, enhancing business stability. However, the Company’s consolidated performance has been sharply impacted by continuing unsustainable low prices in export markets, mainly in Southeast Asia.

 

The acquisition of Novabay Pte. Limited announced during the quarter aligns well with our strategy to focus on high-margin, specialty chemical businesses and deepen our presence in key global markets. It enhances our ability to offer differentiated solutions to customers while reinforcing Tata Chemicals’ long-term growth agenda in value-added products. The transaction is expected to be completed in the Q4FY26, subject to the fulfilment of customary closing conditions.

 

Further today, the Board approved an investment of ₹515 crore for setting up a greenfield manufacturing facility for Iodised Vacuum Salt Dried (IVSD) at Valinokkam, Ramanathapuram district, Tamil Nadu. The proposed facility will have a capacity of 210 kilo tonnes per annum (KTPA). This investment underscores our continued commitment to strengthening our core consumer products portfolio and expanding our manufacturing footprint in India. The proposed facility will enhance our ability to meet growing demand for high-quality iodised salt while supporting long-term, sustainable growth.

 

In response to prevailing market conditions, our priorities remain firmly aligned to protecting margins, preserving cash flows, and maintaining balance sheet strength. We continue to adopt a disciplined approach to capacity utilisation, cost control, and capital allocation, ensuring resilience through the current phase of the cycle.”

 

Consolidated Highlights Q3FY26

● Revenue from operations at ₹ 3,550 Cr, down by 1% compared to Q3FY25, due to subdued market conditions.

● EBITDA at ₹ 345 Cr as compared to ₹ 434 Cr in Q3FY25, mainly on account of subdued pricing across all geographies.

● An exceptional charge of ₹ 54 Cr is provided on account of new labour code.

● Profit After Tax (before exceptional items and NCI) at ₹ (15) Cr compared to ₹ 49 Cr for Q3FY25.

● Net debt as on December 31, 2025, stood at ₹ 5,596 Cr (excluding lease of ₹ 772 Cr).

 

Standalone Highlights Q3FY26

● Revenue from operationsstood at ₹ 1,204 Cr, up by 3% compared to Q3FY25 due to higher volumes.

● EBITDA at ₹ 228 Cr, up by 9% compared to Q3FY25, effect of higher volume and lower fixed costs.

● An exceptional charge of ₹ 14 Cr is provided on account of new labour code.

● Profit After Tax (before exceptional items) from continuing operations was ₹ 87 Cr, up by 21% compared to Q3FY25.

● During the quarter, Pearl Silica facility with a capacity of 3,000 MTPA at Cuddalore, Tamil Nadu, and FOS L55 facility with a capacity of 4,500 MTPA at Mambattu were commissioned.

 

Consolidated Highlights 9MFY26

● Revenue from operations at ₹ 11,146 Cr, down by 2% compared to 9MFY25, due to pricing pressure in all regions and lower volumes except India.

● EBITDA at ₹ 1,531 Cr as compared to ₹ 1,626 Cr in 9MFY25, on account of lower realization but supported by lower fixed cost controls including cessation of Lostock operations in UK.

● Profit After Tax (before exceptional items and NCI) at ₹ 520 Cr compared to ₹ 491 Cr for 9MFY25.

 

Standalone Highlights 9MFY26

● Revenue from operations stood at ₹ 3,577 Cr, up by 11% compared to 9MFY25 due to higher volumes, however realisations impacted due to pricing conditions.

● EBITDA at ₹ 738 Cr, up by 26% compared to 9MFY25, effect of higher volumes and cost control measures taken.

● Profit After Tax (before exceptional items) from continuing operations was ₹ 572 Cr, up by 34% compared to 9MFY25.

Post a Comment

0 Comments